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CASE REPORT
Immunotherapy with bacille Calmette-Guérin
(BCG) in patients with various kinds of malignant
diseases is a widely used treatment method. In par-
ticular, a topical treatment via intravesical instillation
of BCG for superficial cancer or in situ carcinoma of
the bladder has been proven effective.1 Although
BCG is an attenuated strain of Mycobacterium bovis
(M bovis), generalized infections, which may be
lethal, may occur even in the non-immunocompro-
mised host.2,3 Only 5 cases of mycotic aneurysms of
large arteries after BCG therapy have been reported.
We add 3 additional cases of vascular infections and
present our experience with this rare entity. 
PATIENTS AND METHODS
Case 1. A 72-year-old man was admitted with a 1-
week history of pain associated with a mass in the left
groin. Nine months earlier, he had undergone femoro-
femoral crossover bypass grafting with a polytetrafluo-
roethylene graft and bilateral femoropopliteal bypass graft-
ing with reversed saphenous vein for severe occlusive dis-
ease. His medical history was significant for bladder cancer
diagnosed in 1992. This cancer initially was treated with
thiotepa chemotherapy. Three months after he underwent
vascular surgery, he was discovered to have in situ bladder
cancer, which was treated with intravesical BCG instilla-
tions (81 mg/ampule; 10.5 ± 8.7 · 108 colony-forming
units/vial; Theracys, Connaught Laboratories, Ltd,
Willowdale, Ontario, Canada) for 6 weekly treatments. In
the last few months, he had noted intermittent sweating
and flu-like symptoms.
On physical examination, the patient was afebrile. He
had a 3+ right femoral pulse, 2+ left femoral and popliteal
pulses, and bilateral 1+ pedal pulses. In the left inguinal
region, a 4-cm fluctuant mass was identified and confirmed
with duplex ultrasound scanning. The femorofemoral
bypass graft was occluded, with both femoropopliteal
bypass grafts being patent. Aspiration of the mass revealed
a purulent fluid. Gram’s staining method showed no
organisms, and the general culture results of the fluid were
negative. All the blood test parameters were within normal
limits. A computed tomographic (CT) scan of the pelvis
and the legs showed a 2 · 5–cm fluid collection in the left
groin at the level of the attachment of the femorofemoral
crossover bypass graft (Fig 1). At surgery, the femoro-
femoral bypass graft was removed, and a vein patch angio-
plasty of the left common femoral artery and an interposi-
tion vein grafting to the previous left femoropopliteal
bypass graft was performed. Cultures that were taken dur-
ing the operation and sputum cultures identified M bovis.
The patient was discharged home on the fifth postoperative
day with oral antituberculous medications (isoniazid,
ethambutol hydrochloride, and rifampin). The patient
remained well 3 months after surgery, with no signs of
recurrent infection.
Case 2. A 58-year-old man was seen with lower back
pain, low-grade fever, and a 12-lb weight loss in the prior
Mycotic vascular infections of large arteries
with Mycobacterium bovis after intravesical
bacillus Calmette-Guérin therapy
Matthias H. Seelig, MD, W. Andrew Oldenburg, MD, Paul J. Klingler, MD,
Michael L. Blute, MD, and Peter C. Pairolero, MD, Jacksonville, Fla, and
Rochester, Minn
Disseminated infection after intravesical bacille Calmette-Guérin instillation for bladder
cancer is a rare but potential complication. Vascular infection is an additional serious
complication but is seldom reported. We present the first report of a small series of
patients with vascular infections after intravesical bacille Calmette-Guérin instillation,
and we review the related literature.  (J Vasc Surg 1999;29:377-81.)
From the Department of Surgery (Drs Seelig, Klingler, and
Oldenburg), Mayo Clinic Jacksonville, and the Departments of
Urology (Dr Blute) and Surgery (Dr Pairolero), Mayo Clinic
Rochester.
Reprint requests: W. Andrew Oldenburg, MD, Mayo Clinic
Jacksonville, Department of Surgery, 4500 San Pablo Rd,
Jacksonville, FL 32224.
Copyright © 1999 by The Society for Vascular Surgery and
International Society for Cardiovascular Surgery, North
American Chapter.
0741-5214/99/$8.00 + 0 24/4/93330
4 to 6 weeks. His medical history was significant for a
transurethral resection of a bladder tumor 5 years before
admission. Two years later, a recurrent multifocal in situ
carcinoma of the bladder was discovered and subsequent-
ly treated on a protocol that involved photodynamic ther-
apy and BCG instillation.4 The patient underwent treat-
ment weekly for 6 weeks and then monthly for 6 months.
Despite this treatment, a repeated in situ carcinoma was
found in the bladder wall and a radical cystoprostatectomy
was recommended. Unfortunately, as a result of the
patient’s presenting symptoms, this procedure was post-
poned.
A CT scan of the abdomen revealed a discrete area of
adenopathy at the aortic bifurcation that was believed to
be caused by metastatic disease. The results of 2 CT
scan–guided needle biopsies of this area showed necrotic
and nondiagnostic inflammatory tissue only. The diagno-
sis of a chronic rupture of an aneurysm was considered. At
surgery, no intra-abdominal disease was found except a 4
· 6–cm lobulated, pulsatile, soft tissue mass that sur-
rounded the aorta and was consistent with an inflammato-
ry aneurysm. Several periaortic lymph nodes were biopsied
and were reported to contain noncaseating granulomas.
After the opening of the aorta, an aortic perforation that
laterally extended posterior to the inferior vena cava was
discovered. The periaortic tissue was fibrotic and inflamed,
but no gross purulence was encountered. The aorta
underwent endarterectomy, and a 16 · 8–mm Dacron
bifurcated graft was placed in the bed of the resected
aneurysm and wrapped with an omental graft that isolated
it from the aortic bed. The acid-fast stain results from the
periaortic tissue were positive. After surgery, the culture
results from the periaortic tissue were returned as positive
for M bovis, which was consistent with the BCG strain
that was confirmed further with phage typing. The patient
was discharged home on a regimen of isoniazid and
rifampin. Ten months later, the patient underwent an
uneventful radical cystoprostatectomy and ileal conduit
urinary diversion. The patient was maintained on isoniazid
and rifampin for 1 year. At follow-up, 11 years after his
vascular operation, he is well and a CT scan of the
abdomen reveals no recurrent disease.
Case 3. A 71-year-old man was referred for an evalu-
ation of fever of unknown origin and a nonhealing lower
extremity ulcer. Eight years before admission, bilateral
popliteal artery aneurysms were repaired with bilateral
popliteal interposition bypass grafts. Four years before
admission, the patient underwent cystoscopic resection
and intravesical thiotepa therapy for superficial grade-1
transitional cell carcinoma of the bladder that was fol-
lowed by intravesical BCG therapy for 1 year. Towards the
end of the BCG treatments, the patient reported having 3
days of malaise after each instillation of BCG, and, there-
fore, the BCG therapy was stopped. The patient subse-
quently remained free of recurrent bladder cancer.
Thirteen months before admission, a pseudoaneurysm
of the right lower extremity formed and necessitated the
repair and revision of his prior bypass graft. The bacterial
cultures of the resected aneurysm revealed no growth.
Four months later, the patient had a low-grade fever,
arthralgia, and myalgia. His erythrocyte sedimentation
rate was markedly elevated. His symptoms subsided after
the initiation of empiric treatment with corticosteroids
(prednisone, 20 mg/day). Six months before the current
admission, a recurrent pseudoaneurysm of the right lower
extremity bypass graft necessitated the removal of all pros-
thetic material and the bacterial cultures of the aneurysm
again showed no organisms. Despite this, the patient con-
tinued to have low-grade fevers and had a persistent non-
healing right lower extremity wound that led to his refer-
ral to our institution.
On physical examination, the patient had a fever of
38.5°C. There was a 4 · 14–cm skin lesion inferomedian
to the right knee, the entire right knee was swollen and
tender, and the distal pulses were diminished. The exami-
nation revealed a hemoglobin concentration of 9.6 g/dL,
a white blood cell count of 8300/m L, a erythrocyte sedi-
mentation rate of 46 mm/h, and a creatinine level of 1.7
mg/dL. The chest radiography film findings were normal,
and no signs of osteomyelitis of the right lower extremity
could be found on the multiple radiographic studies. The
cultures of knee wound specimens, which included
mycobacterial cultures, revealed a growth of Staphylococcus
aureus and Pseudomonas aeruginosa, and the patient was
administered appropriate antibiotics. A CT examination of
the abdomen and pelvis was performed and showed a 6-
cm aneurysm of the lower abdominal aorta (Fig 2).
Angiography results confirmed the presence of a saccular
infrarenal abdominal aortic aneurysm (Fig 3). The patient
subsequently underwent an excision of the abdominal aor-
tic aneurysm with the placement of an aortic right com-
mon iliac artery bypass graft in the uninfected planes. The
left iliac artery was perfused in a retrograde fashion with
an intact aortic bifurcation. The graft was covered with an
omental flap. A special staining of the aneurysm showed
many acid-fast bacilli. The cultures of the aneurysm grew
M bovis that was sensitive to isoniazid, rifampin, strepto-
mycin, and ethambutol hydrochloride and was resistant to
pyrazinamide. The bacterial and fungal cultures were
without growth.
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Fig 1. Computed tomographic scan shows left groin fluid
collection around anastomosis of femorofemoral crossover
bypass graft and the left common femoral artery (fi ).
After an uneventful postoperative recovery, the patient
underwent treatment with isoniazid, rifampin, and etham-
butol hydrochloride for 2 months, which was followed by
10 months of isoniazid and rifampin therapy. The
mycobacterial cultures of the knee and the wound were
without growth. Four years later, the patient was well,
without fever or signs of continued infections.
DISCUSSION
BCG is an attenuated strain of M bovis, which
originally was used for vaccination against tubercu-
losis. Additional indications for BCG are immu-
notherapy for solid tumors, such as malignant
melanomas, and intravesical treatment for transition-
al cell carcinoma of the bladder.1,5 BCG has been
postulated to stimulate a complex immune reaction
in the surrounding tissue, which finally leads to
tumor-cell destruction.
Systemic complications after the intravesical
instillation of BCG have been reviewed extensively.6
The complications include high-grade fever, sepsis,
granulomatous pneumonitis and hepatitis, and
arthralgia. Several cases that indicated the metastatic
spread of BCG have been reported, including the
development of vertebral osteomyelitis,7 the infec-
tion of an automatic implantable cardiac converter,8
and psoas abscess.9
The detection of M bovis in the cultures that
were taken from the infected aneurysm or graft has
been considered to prove a BCG-induced infection.
With polymerase chain reaction analytic methods
with primers from repetitive DNA sequences of
Mycobacterium tuberculosis that crossreact with M
bovis,10 BCG infection may be diagnosed even in a
formalin-fixed and paraffin-embedded aortic wall
years after the initial event. Recently, a specific
genomic region RD1 was found to be present in all
virulent strains of M bovis and Mycobacterium
tuberculosis but deleted from all BCG strains that
were tested, which allows a rapid and specific identi-
fication of BCG with the polymerase chain reaction
method.11
Since the introduction of intravesical BCG ther-
apy for superficial bladder cancer in 1974, only 5
cases of vascular infections after intravesical BCG
therapy have been reported.2,3,12-14 An additional
case of a mycotic aortic aneurysm was observed after
intralesional BCG injections into a satellite metasta-
sis of a malignant melanoma in the leg.15 An
overview of the reported cases is given in Table I.
Two patients (nos. 3 and 4) died as a result of
mycobacterial sepsis, whereas 1 patient (no. 6) died
of an unrelated disease. The diagnosis of a mycotic
aneurysm was made retrospectively in 1 patient with
genetic testing of the resected aneurysmal specimen.
One year after the aneurysm repair, a fluid collection
had developed around the graft, which was aspirated
and grew M bovis on a culture. Despite the proba-
ble graft infection, a course of conservative antimy-
cotic chemotherapy was chosen. Subsequently, an
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Fig 3. Angiogram of saccular mycotic aneurysm.
Fig 2. Computed tomographic scan of saccular mycotic
aneurysm.
aortoenteric fistula developed in the patient and
necessitated an emergent laparotomy.
Vascular infections with M bovis may occur with
direct extension from an infected lesion, such as a
vertebral osteomyelitis or a para-aortic lymph
node.16 Metastatic implantation of M bovis to the
vasa vasorum of the arterial wall through hematoge-
nous dissemination followed by inflammation and
necrosis of the media and the adventitia may be
another port of entry. The risk of metastatic spread
may be significantly increased when the bladder
epithelium is grossly disrupted, and, therefore, it has
been proposed to delay BCG instillation after
transurethral resection of bladder cancer, after blad-
der biopsy, or after traumatic catheterization. Direct
intralesional injection of BCG for solid tumors may
be associated with a higher rate of complications
because many tumors are well vascularized, which
allows early access to the circulation.
There are several treatment options for a vascu-
lar infection. These options include in situ repair,
retroperitoneal in-line aortic bypass grafting, and the
resection of the involved artery or graft with the cre-
ation of an extra-anatomic bypass graft.17 In situ
repair should be used only when no frank purulence
is encountered or when the graft can be isolated
from the surrounding infected tissue. As long as
prosthetic material is used, there remains the possi-
bility for subsequent graft infection. Another option
may be in situ reconstruction with autologous vein
grafts, such as superficial femoral vein or greater
saphenous vein. Endoluminal repair without resec-
tion or debridement of the infected tissues has been
reported,12 but the grafts may also become infected.
Therefore, this treatment should be reserved for
poor surgical candidates. A conservative treatment
may result in a fatal outcome.13
Besides the surgical repair, appropriate antibiotic
chemotherapy is the cornerstone of effective man-
agement of mycotic aneurysms that are caused by M
bovis. M bovis usually is sensitive to isoniazid, strep-
tomycin, ethambutol hydrochloride, and rifampin.
However, all strains are resistant to pyrazinamide.
Combination antituberculous chemotherapy should
be maintained for 6 to 12 months.
The institution of prophylactic antituberculous
treatment has been proposed if systemic reactions
occur during treatment with intravesical BCG appli-
cation. Prophylactic antituberculous treatment in
patients with a new vascular graft (<6 months) who
need intravesical BCG treatment may be beneficial
in reducing the subsequent risk of graft infection. In
addition, these patients should be followed on a reg-
ular basis with ultrasound or CT scanning to exclude
any graft abnormalities. However, a decrease in the
side effects of the patients who receive prophylactic
isoniazid medication during intravesical BCG treat-
ments has not been shown.18 Prophylactic antitu-
berculous medications may reduce the effectiveness
of the BCG therapy by inhibiting the intended anti-
tumor activity.19 Currently, the European
Organization for Research and Treatment of Cancer
protocol 30911 is being conducted to assess
whether isoniazid decreases antitumorigenic effects
in patients treated with intravesical BCG. These
results have not yet been published. 
BCG therapy may be accompanied by M bovis
infection, which may result in a vascular infection.
Effective therapy consists of the resection of the
involved artery or graft and bypass grafting. Multiple
cultures, including mycobacteria, are mandatory. If
the M bovis infection is detected, antituberculous
chemotherapy for at least 6 to 12 months is essential
to eradicate the organism. 
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Table I. Overview of all reported cases of vascular infections after intravesical bacille Calmette-Guérin therapy 
for superficial bladder cancer or after intralesional bacille Calmette-Guérin therapy for melanoma
Patient sex Patient
Case no. Author Year (M/F) age (years) Site of lesion
1 Woods et al15 1988 F 62 AAA
2 Bornet et al14 1989 M 74 Bilateral FAA
3 Deresiewicz et al3 1990 M 67 AAA and IAA
4 Izes et al2 1993 M 69 Aneurysm aortic arch
5 Wolf et al13 1995 M 80 Ruptured AAA
6 Rozenblit et al12 1996 M 76 AAA, vertebral osteomyelitis
7 Present series 1998 M 72 Left-sided infection of femorofemoral graft
8 Present series 1998 M 58 AAA
9 Present series 1998 M 71 AAA
BCG, Bacille Calmette-Guérin; AAA, abdominal aortic aneurysm; PTFE, polytetrafluoroethylene; FAA, femoral artery aneurysm; IAA,
iliac artery aneurysm.
*Interval between intravesical bacille Calmette-Guérin instillation and presentation for vascular infection.
†Interval between treatment and death not given.
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Time interval Follow-up
BCG instillation (months)* Treatment after diagnosis (months)* Outcome
Melanoma right leg 18 PTFE tube graft 4 No recurrence
Bladder 27 PTFE graft, reversed saphenous vein 18 No recurrence
Bladder 14 Axillobifemoral graft † Death
Bladder 36 Conservative 0 Death
Bladder 24 Dacron aortobifemoral graft 32 Aortoenteric fistula
Bladder 69 Dacron endovascular stent graft 15 Death
Bladder 6 Vein interposition graft, vein patch angioplasty 3 No recurrence
Bladder 30 Aortic endarterectomy, Dacron aortobifemoral graft 128 No recurrence
Bladder 53 Aorto-right common iliac artery Dacron graft 48 No recurrence
